Kevin Hershberger is the founder of Lumicell. Lumicell has raised $33M in total funding. Latest round: Series C. Based in Newton, United States.
Kevin Hershberger serves as the President & CEO of Lumicell, a medical device company specializing in innovative fluorescence-guided technologies for cancer surgery. Lumicell's Lumicell Direct Visualization System (DVS) aims to improve outcomes, initially focusing on breast cancer, by guiding the real-time removal of residual cancer during surgery. The company has treated over 700 patients in breast cancer trials and has submitted applications for FDA approval for its LUMISIGHT Optical Imaging Agent and Lumicell DVS.
Full founder directory · Investor directory · Company funding database · Fundraising library